Core Viewpoint - Compass, Inc. has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Recent Developments for Compass - Compass is expected to earn -$0.33 per share for the fiscal year ending December 2024, reflecting a year-over-year change of 52.2% [8]. - Over the past three months, the Zacks Consensus Estimate for Compass has increased by 251%, indicating a strong upward trend in earnings estimates [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - The upgrade of Compass to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Company Overview - Compass, Inc. (COMP) shares increased by 19.4% to close at $6.66, following a period of 16.7% loss over the past four weeks, indicating a significant recovery in stock performance [1] - The company is experiencing strong transaction growth, record agent retention, and enhanced operational efficiencies, which have led to an upward revision of its revenue forecasts for Q4 2024 and full-year 2024 [2] Financial Performance - The revised revenue forecast for Q4 2024 is now between $1.36 billion and $1.39 billion, up from the previous estimate of $1.225 billion to $1.325 billion [2] - The full-year 2024 revenue forecast has also been increased to between $5.61 billion and $5.64 billion, compared to the earlier forecast of $5.47 billion to $5.57 billion [2] - The upcoming quarterly report is expected to show a loss of $0.10 per share, which represents a year-over-year change of +41.2%, with revenues anticipated to be $1.28 billion, reflecting a 16.7% increase from the previous year [3] Market Sentiment - The consensus EPS estimate for Compass has remained unchanged over the last 30 days, suggesting stability in earnings expectations [4] - The stock currently holds a Zacks Rank of 1 (Strong Buy), indicating positive market sentiment towards its future performance [4] - In comparison, DigitalOcean Holdings, Inc. (DOCN), another company in the same industry, has a Zacks Rank of 3 (Hold) and has seen a decline of 11.1% over the past month [4][5]

Financial Performance - Compass raised its full-year revenue guidance to $5.61 billion to $5.64 billion, up from the previous outlook of $5.47 billion to $5.57 billion [1] - Full-year adjusted EBITDA is now expected to be $124 million to $127 million, compared to the earlier estimate of $109 million to $119 million [1] - Fourth-quarter revenue guidance increased to $1.36 billion to $1.39 billion, up from $1.225 billion to $1.325 billion [5] - Fourth-quarter adjusted EBITDA guidance raised to $15 million to $18 million, from $0 to $10 million previously [5] Operational Highlights - Compass recruited more than 650 principal agents organically in Q4, a 50% increase compared to the same period last year [3][6] - The company's ability to outperform the market while maintaining operating expense discipline was highlighted by the CEO [3] - Compass shares surged nearly 20% following the improved guidance and operational updates [5] Market Performance - Compass shares were up 18% an hour after the opening bell on the day of the announcement [3] - The company's stock has nearly doubled in value over the past year [3]

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long positio ...

NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) ("Compass"), the largest residential real estate brokerage in the United States by sales volume1 announces the participation of CEO & Founder Robert Reffkin and CFO Kalani Reelitz at the 27th Annual Needham Growth Conference. The event will take place on January 15, 2025, at the Lotte NY Palace Hotel.Reffkin and Reelitz will be participating in fireside chat at 8:00 a.m. ET followed by one-on-one and group meetings with investors for the rema ...

Modern commercial data helps organizations find new patients and HCPsPLEASANTON, Calif., Dec. 12, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced increasing momentum for Veeva Compass Patient, an emerging leader for anonymous patient longitudinal data. With unlimited data access, daily data, and the most complete data network supporting both retail and specialty brands, Compass Patient helps commercial teams at biopharmas of all sizes better support key use cases like patient journey, market ...

Christie's International Real Estate Has 100+ Affiliates in Almost 50 Countries and Territories Around the World and Maintains a Close Partnership with the Christie's Auction House @properties is the 8th Largest Residential Brokerage in the US by Sales Volume1Best-in-Class Title & Mortgage Offerings in Key Markets Will Also Be IncludedNEW YORK, Dec. 2, 2024 /PRNewswire/ -- Compass Inc. (NYSE: COMP) ("Compass"), Christie's International Real Estate, and @properties have announced that they will be joining fo ...

Flora Launches Limited Edition Compass Rise Crimson, Perfectly Timed for the Holiday SeasonDecember 02, 2024 9:17 AM EST | Source: Flora Growth Corp.Fort Lauderdale, Florida--(Newsfile Corp. - December 2, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is thrilled to announce the launch of the limited-edition Compass Rise Crimson. This exclusive offering, a new addition to the acclaimed Compass Rise Series, is available just in time for the holidays, promising ...

BOSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Piper Sandler 36th Annual Healthcare Conference taking place in New York City, NY December 3-5, 2024. Presentation detailsDate: Wednesday, December 4, 2024Time: 9:50-10:10 AM ESTWebcast Link: https://event.webcasts.com/ Virtual/ ...

One of our Preferred stock picks being called in 2024 has delivered a 27%-plus return, and there's more where that came from.With Hidden Dividend Stocks Plus he scours the world's markets to find solid income opportunities with dividend yields ranging from 5% to 10% or more, backed by strong earnings. Features include: a portfolio with up to 40 holdings at a time including links to associated articles, a dividend calendar, weekly research articles, exclusive ideas, and trade alerts. Learn More .Robert Hauve ...